Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001078782-13-000187
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-25 20:15:33
Reporting Period:
2013-01-23
Filing Date:
2013-01-25
Filing Date Changed:
2013-01-25
Accepted Time:
2013-01-25 20:15:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1101026 Health Enhancement Products Inc HEPI Food And Kindred Products (2000) 870699977
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436075 D. Christopher Maggiore 4788 Nobles Pond Dr. Nw
Canton OH 44718
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-23 5,625 $0.25 11,176,540 No 4 P Direct
Common Stock Acquisiton 2013-01-24 11,000 $0.24 11,187,540 No 4 P Direct
Common Stock Acquisiton 2013-01-25 184,500 $0.26 11,372,040 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. The shares were purchased in multiple same day transactions at prices ranging from $0.2475 to $0.2599. The reporting person undertakes to provide Health Enhancement Products, Inc. and its securityholders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. The price reported in column 4 is a weighted average price. The shares were purchased in multiple same day transactions at prices ranging from $0.235 to $0.2375. The reporting person undertakes to provide Health Enhancement Products, Inc. and its securityholders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. The price reported in column 4 is a weighted average price. The shares were purchased in multiple same day transactions at prices ranging from $0.24 to $0.27. The reporting person undertakes to provide Health Enhancement Products, Inc. and its securityholders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.